跳至主要内容
临床试验/IRCT20160919029871N3
IRCT20160919029871N3招募中3 期

The role of topical NSAIDs on inflammation and anterior segment complications after cataract surgery in patients with pseudoexfoliation syndrome

Guilan University of Medical Sciences0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 95 years(—)
性别
All

入选标准

  • Having Significant cataract (grade 3 and higher) and clinical signs of PEX.
  • The patient should not be used systemic or inhaled NSAIDs within 1 week before surgery and the patients should not use the inhaled or systemic corticosteroids within 15 days after surgery

排除标准

  • Having known hypersensitivity to any components of the NSAIDs
  • uncontrolled chronic ocular or systemic inflammatory disease; a history of eye trauma and any retinal and macular disease, any intraocular complication during surgery (vitreous loss)
  • The patient who must be treated with systemic anti-inflammatory medications for extensive inflammation following cataract surgery

研究者

发起方
Guilan University of Medical Sciences

相似试验